News | January 14, 2009

Varian’s Clinac DHX Now Available in Estonia

January 15, 2008 - Cancer patients in Estonia now have access to advanced radiotherapy techniques— including intensity modulated radiotherapy (IMRT)— with the official unveiling shortly before Christmas of an advanced Varian Medical Systems treatment machine at the North Estonia Regional Hospital in the country's capital, Tallinn.

North Estonia Regional Hospital, which serves two-thirds of Estonia's 1.4 million population, has doubled its linear accelerator capacity with the acquisition of a Varian Clinac DHX equipped with a Millennium 120-leaf collimator, enabling more conformal radiotherapy treatment

This workload increased shortly after the new machine arrived, when an older device at the only other Estonian radiotherapy hospital broke down and all that hospital's patients were transferred to the North Estonian Regional Hospital. "At present we are the only hospital in the country treating patients with a linear accelerator and we are extremely busy," said Dr. Maire Kuddu, chief radiation oncologist. Staff at the hospital are working double-shift on both machines as they attempt to cope with more than 130 patients a day.

Despite this heavy workload, the team has been able to introduce advanced IMRT for head and neck cancer patients. Intensity modulated radiotherapy enables clinicians to 'sculpt' the dose to the shape of the tumor and avoid more surrounding healthy tissue. For head and neck patients, it means more precise treatments and less potential harm to nearby salivary and parotid glands.

For more information: www.varian.com

Related Content

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...
non-small cell lung cancer, NSCLC, IMRT, toxicity, intensity modulated radiation therapy, 3-D CRT, ASTRO 2015
News | Lung Cancer | October 28, 2015
October 28, 2015 — An analysis of an international, cooperative-led trial of patients with locally advanced non-small
pediatric ependymoma patients, immediate post-surgical radiation therapy, Children's Oncology Group ACNS0121 trial, ASTRO 2015
News | Radiation Therapy | October 22, 2015
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative...
post-prostatectomy IG-IMRT, image-guided intensity-modulated radiation therapy, toxicity, ASTRO, Practical Radiation Oncology
Feature | Intensity Modulated Radiation Therapy (IMRT) | October 06, 2015
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in...
Gustave Roussy, Elekta, Versa HD, linear accelerators, Mosaiq, France

Image courtesy of Elekta

News | Radiation Therapy | September 04, 2015
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing...
Overlay Init